Maximum quantity allowed is 999
Please select the quantity
CAS RN: 278779-30-9 | Product Number: G0648
GW 4064
×
![]()
×
Purity: >95.0%(HPLC)(qNMR)
Synonyms:
- 3-[2-Chloro-4-[[3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy]styryl]benzoic Acid
- 3-[2-[2-Chloro-4-[[3-(2,6-dichlorophenyl)-5-isopropyl-1,2-oxazol-4-yl]methoxy]phenyl]vinyl]benzoic Acid
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 10MG |
₩201,700
|
8 | 0 | It can be shipped in about 2 weeks after ordering | |
| 50MG |
₩706,700
|
8 | 0 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
| Product Number | G0648 |
| Purity / Analysis Method | >95.0%(HPLC)(qNMR) |
| Molecular Formula / Molecular Weight | C__2__8H__2__2Cl__3NO__4 = 542.84 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Hygroscopic,Heat Sensitive |
| CAS RN | 278779-30-9 |
| Reaxys Registry Number | 10125635 |
| MDL Number | MFCD09971006 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(qNMR) | min. 95.0 % |
| Melting point | 173.0 to 177.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 175 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. H319 : Causes serious eye irritation. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear eye protection/ face protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
Transport Information:
| H.S.code* | 2934.99-000 |
Application
GW 6064: The First Non-Steroidal and Selective Farnesoid X Receptor (FXR) Agonist
The farnesoid X receptor (FXR) is a bile acid-activated nuclear receptor (BAR) expressed primarily in the liver and intestine.1) FXR plays important roles not only in bile acid, lipid metabolism, and carbohydrate homeostasis, but also in inflammatory responses.2) GW 6064 is the first non-steroidal and selective FXR agonist with decent submicromolar potency and has been used to study the role of FXR in dyslipidemia, diabetes, obesity and cancer.2,3) (The product is for research purpose only.)
References
- 1) Liver X Receptor and Farnesoid X Receptor as Therapeutic Targets
- 2) Role of farnesoid X receptor in inflammation and resolution (a review)
- 3) Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.